AstraZeneca tamoxifen

Triphenylethylenes Tamoxifen Clomifene Toremifene Droloxifene Miproxifene (TAT-59) Idoxifene Ospemifene (FC- la)1 Fispemifene GW5638 MDL 103,323 AstraZeneca Orion Pfizer Taiho Pharm SmithKline Beecham Hormos Medical Corp Hormos Medical Corp Duke University Hoechst-Marion-Roussel... [Pg.65]

Tamoxifen (Nolvadex /AstraZeneca), a nonsteroidal antiestrogen chemotherapeutic possessing both agonistic and antagonistic properties, is used for the treatment and preven-... [Pg.422]

Tamoxifen citrate Nolvadex-AstraZeneca, and others Tamofen in Canada)... [Pg.400]

Nolvadex (tamoxifen) product information. AstraZeneca Pharmaceuticals LP, June 2003. [Pg.2363]

Nolvadex (Tamoxifen). AstraZeneca Pharmaceuticals. US Prescribing information, March... [Pg.454]

NolvadexD (Tamoxifen). AstraZeneca UK Ltd. UK Summary ofproduct characteristics, July 2005. [Pg.616]

Tamoxifen 449 is known as an estrogen antagonist and effective for metastatic breast cancer. Tamoxifen is the typical regiment for hormone receptor-positive breast cancer in premenopausal women, and it was developed by ICI Pharmaceuticals (now AstraZeneca, London, U.K.) under the trade names of Nolvadex, Istubal, and Valodex. While the previous synthetic approaches involved stoichiometric reagents or a multistep synthetic manipulations, Taniguchi applied his stereoselective copper-catalyzed alkyne functionalization to introduce halide and sulfide groups (Scheme 46.51) and to provide an access to 447. " In this approach, tamoxifen 449 was prepared in three steps from diphenyl acetylene 445 as a starting material with 51% overall yield 7JE = 93/7). [Pg.1432]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...